Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-122482
Filing Date
2025-05-19
Accepted
2025-05-19 16:30:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d934443ddefa14a.htm DEFA14A 18870
2 GRAPHIC g934443g0519042710253.jpg GRAPHIC 13118
  Complete submission text file 0001193125-25-122482.txt   38126
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 25964430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)